The global peripherally inserted central catheter market size is estimated to reach USD 1,037.0 million in 2024. Over the projection period, global demand for peripherally inserted central catheters (PICCs) is anticipated to rise at a CAGR of 2.2%. By 2034, global peripherally inserted central catheter revenue is set to total USD 1,289.8 million.
In 2023, the global market for peripherally inserted central catheters accounted for about 38.6% of the overall central venous catheter market, valued at USD 2,543.9 million. This share will likely increase further amid growing adoption of PICCs in treatment procedures.
Key Factors Expected to Drive Growth of the Peripherally Inserted Central Catheter (PICC) Market
| Attributes | Key Insights |
|---|---|
| Based Market Value (2023) | USD 1,008.5 million |
| Estimated Peripherally Inserted Central Catheter Market Size (2024) | USD 1,037.0 million |
| Projected Market Value (2034) | USD 1,289.9 million |
| Value CAGR (2024 to 2034) | 2.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing usage of peripherally inserted central catheters (PICCs) for administering intravenous fluids, medications, nutrients, and blood transfusions is expected to boost. These catheters are inserted into a blood vessel of patients’ arm and passed to larger veins near the heart to deliver medications and other products.
Peripherally inserted central catheters (PICCs) are witnessing a significant upward trajectory due to the growing demand for patient-centric solutions. Since PICC lines are less invasive than standard central venous catheters, patients are increasingly opting for them. A fundamental change toward comfortable, personalized healthcare experiences is the driving force behind this movement.
Rising geriatric population is another key factor expected to drive demand for peripherally inserted central catheters. This is because older people are more susceptible to chronic conditions like renal diseases and congestive heart failure that require PICCs.
Peripherally inserted central catheters are becoming popular among healthcare providers due to their reduced risk of infection. These catheters have lower risk of infection compared to conventional central venous catheters.
Global sales of peripherally inserted central catheters (PICCs) recorded a CAGR of 2.1% during the historical period. Total market valuation reached around USD 1,008.5 million in 2023. In the forecast period, the worldwide peripherally inserted central catheter industry is expected to grow at 2.2% CAGR.
| Historical CAGR (2019 to 2023) | 2.1% |
|---|---|
| Forecast CAGR (2024 to 2034) | 2.2% |
Increasing incidence of chronic diseases, particularly cancer, is a key factor expected to propel demand for peripherally inserted central catheters. This can be attributed to rising usage of PICCs during cancer treatments.
Cancer is one of the leading causes of death globally and an important barrier to raising life expectancy. As per the World Health Organization's (WHO) 2019 estimations, cancer ranks first or second in 112 out of 183 nations and ranks third or fourth in 23 other countries as the primary cause of death before the age of 70.
In certain countries, the mortality rates from stroke and coronary heart disease have significantly decreased in comparison to cancer. This contributes to the growing prominence of cancer as a primary cause of death.
Patients with cancer frequently need lengthy, intense treatments like chemotherapy, which requires consistent IV access. PICC catheters' flexibility and ability to offer long-term vascular access have made them essential components of cancer care.
The need for efficient and convenient management of chemotherapy medications and other supportive treatments is growing along with the number of cancer cases. PICC lines provide a less invasive alternative to conventional central venous catheters, reducing the discomfort linked to recurrent needle sticks. Typically performed as an outpatient procedure, their implantation enhances patient comfort and permits ongoing therapy in a home environment.
PICC catheter use has also increased as a result of the move toward customized cancer therapy and the delivery of multiple medications. These catheters eliminate the need for numerous venipunctures by giving different drugs a central route. The need for peripherally inserted central catheters (PICCs) is significantly increasing with the rising incidence of cancer.
Apart from this, long-term medical procedures are becoming increasingly necessary as the world's population ages and the prevalence of chronic disorders grows. With the focus on patient comfort and affordable care, home healthcare has emerged as the sensible option.
Patients facing chronic disorders frequently need long-term intravenous therapies, like chemotherapy or antibiotics. PICC catheters, which offer a dependable and less intrusive method of vascular access, are essential to the success of various treatments. PICCs enable people to receive complex medical care in the comfort of their own houses, reducing the need for repeated hospital visits.
Amid increasing prevalence of cancer and surging demand for home healthcare, the peripherally inserted central catheter industry is anticipated to witness steady growth. It will likely attain a valuation of USD 1,289.9 million by the end of 2034.
Principal Consultant
Emerging economies such as India, China, Brazil, Mexico, and South Africa have a large number of under-served patients. These geographies represent a significant opportunity for medical device manufacturers. Economic development in these emerging economies, coupled with the rising disposable incomes of patients, will help the market ensure future sustainability.
Hospitals and other healthcare facilities in these regions are increasingly adopting advanced medical devices such as peripherally inserted central catheters (PICCs). This is due to the expansion of the healthcare infrastructure, growing cancer burden, and rising government spending on healthcare.
The need for modern medical advances that enhance patient care is rising at the same time. As a result, governments are allocating more funds to upgrade healthcare facilities. This will likely foster growth of the peripherally inserted central catheter (PICC) market.
PICC catheters can be essential to delivering effective and extended IV access. Hence, growing incidence of chronic diseases and rising adoption of PICCs in chemotherapies, parental nutrition, and long-term IV infusions will create growth opportunities for PICC manufacturers.
The increased spending on healthcare makes it easier for new manufacturers to enter the global PICC market. This encourages competition and innovation and may result in lower pricing.
Increasing patient pool and rise in disposable incomes are expected to create opportunities for the peripherally inserted central catheter market. Similarly, increasing number of hospitals in emerging economies will uplift demand for peripherally inserted central catheters (PICCs).
Several guidelines have been created by regulatory bodies and international panels of nephrologists, oncologists, interventional radiologists, and surgeons. For instance, The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) was published in 2015.
These guidelines advise non-tunneled central lines for patients with serious medical conditions who require access for less than 14 days and midlines or peripheral IV lines for patients who require access for less than 14 days. The implementation of the MAGIC guideline has been demonstrated to lower the adoption of PICCs in individual institutions.
PICC placement volume by doctors and APPs decreased over time, falling from 243,837 in 2010 to 130,361 in 2018 (46.5%). After the 2015 release of the MAGIC guidelines, there was a significant decline in the volume of PICC placements. Hence, such stringent regulatory guidelines could restrain the growth of the peripherally inserted central catheter market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
This section highlights the PICC market across prominent countries. China and India are predicted to register higher CAGRs of 5.5% and 5.6%, respectively, through 2034. Information provided in this section can help businesses expand their presence in nations that can provide lucrative revenue-generation opportunities.
Market Growth Outlook by Key Countries
| Countries | Value CAGR |
|---|---|
| United States | 1.2% |
| Germany | 1.2% |
| United Kingdom | 1.6% |
| China | 5.5% |
| India | 5.6% |
The United States peripherally inserted central catheter market size is set to grow with a CAGR of 1.2% during the forecast period. It will likely attain a market valuation of USD 545.82 million by the end of 2034, owing to factors like:
The United States is witnessing a rise in chronic conditions such as cancer, cardiovascular diseases, and kidney disorders. This, in turn, is creating a need for medical interventions requiring PICCs, thereby fostering market growth.
China is expected to emerge as a highly lucrative market for PICC manufacturers during the forecast period. As per the latest report, sales of peripherally inserted central catheters in China are set to rise at 5.5% CAGR, totaling a valuation of USD 87.15 million by 2034. This is attributable to factors like:
According to United Nations world population projections, the number of older people in China is expected to reach 483 million in 2050. As the population ages, the prevalence of age-related diseases also increases.
Chronic diseases such as cancer, cardiovascular disease, and kidney disease are more common in the elderly. These conditions often require long-term treatments and interventions, including the use of peripherally inserted central catheters for chemotherapy, dialysis, and intravenous therapies. This is expected to boost China PICC market through 2034.
The below section provides deeper insights into leading segments and their respective shares in the peripherally inserted central catheter market. This information can help companies to invest in demanding products and find the most profitable distribution channels for their business.
Market Growth Outlook by Key Product
| Product | Value CAGR |
|---|---|
| Conventional PICC | 0.8% |
| Power Injected PICC | 2.2% |
| Neonatal PICC | 4.4% |
Power injected peripherally inserted central catheters (PICCs) remain the most popular products in the market. This is due to several advantages offered by these power injected PICCs.
As per the latest analysis, power injected PICC segment is expected to account for a prominent revenue share of 54.3% in 2034. Over the forecast period, demand for power injected PICCs will likely increase at 2.2% CAGR, owing to their advantages such as:
Power injected PICCs are becoming ideal alternatives to traditional PICCs. They are a safe and effective option for patients requiring benefits of rapid fluid delivery. These central venous catheters are widely used for the rapid injection of fluids like contrast media for CT scans.
In diagnostic conditions, the power injection ability makes it possible to efficiently deliver contrast solutions for imaging examinations like CT scans. This advantage lowers the need for additional venipuncture and improves workflow efficiency, which is also one of the key reasons for higher adoption of power-injected PICCs in clinical practice.
Market Growth Outlook by Key Lumen
| Product | Value CAGR |
|---|---|
| Single Lumen | 1.4% |
| Double Lumen | 3.0% |
| Multiple Lumen | 2.0% |
Double lumen PICCs are becoming popular in the global peripherally inserted central catheter industry. This is because they allow for simultaneously administering multiple fluids, medications, or blood products.
The double lumen segment is projected to total USD 610.65 million in 2034, holding a market share of 47.3%. Overall demand for double lumen PICCs is set to grow at 3.0% CAGR, making it the top-revenue generation segment.
PICCs with two lumens enable the simultaneous delivery of fluids and drugs, making them suitable for various clinical conditions. Due to their effectiveness, fewer catheter insertions are necessary, which enhances patient comfort and reduces difficulties.
Market Growth Outlook by Key Application
| Application | Value CAGR |
|---|---|
| Chemotherapy | 4.7% |
| Long-term IV Infusion | 0.8% |
| Parenteral Nutrition | 4.1% |
| Blood Transfusion | 5.5% |
| Difficult Intravenous Access | 1.3% |
| Others | 2.2% |
As per the latest peripherally inserted central catheter market analysis, PICCs are mostly employed for long-term IV infusion applications. The target segment is poised to hold a dominant value share of 36.5% by 2034.
Peripherally inserted central catheters provide an essential connection for long-term intravenous medicine infusion, ensuring a dependable and long-lasting access point. PICC lines are ideal for long-term therapies because they allow for continuous medication delivery, enhancing patient comfort and treatment acceptance.
Market Growth Outlook by Key End User
| End User | Value CAGR |
|---|---|
| Hospitals | 0.7% |
| Cancer Research Institutes | 5.4% |
| Long Term Care Centers | 3.5% |
| Independent Infusion Centers | 3.8% |
| Ambulatory Surgical Center | 1.6% |
| Home Care Settings | 2.3% |
The hospitals segment is a leading end user of the peripherally inserted central catheters. It is projected to hold a value share of 36.1% by the end of 2034.
Hospitals deal with a wide range of medical problems, mostly involving patients with complicated medical conditions requiring continuous IV access. As a result, demand for PICCs remains high in hospital settings.
Hospitals also execute more surgeries, therapies, and diagnostic imaging procedures. These procedures may require using PICCs for long-term intravenous access, medicine delivery, and contrast administration.
The improvement of product features is a top priority for key manufacturers of peripherally inserted central catheters to strengthen their position in the market. Several key peripherally inserted central catheter companies are also entering into strategic alliances and agreements with other businesses to broaden their market reach.
Recent Developments in the Peripherally Inserted Central Catheter Market
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | USD 1,037.0 million |
| Projected Market Size (2034) | USD 1,289.9 million |
| Expected Growth Rate (2024 to 2034) | 2.2% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; South Asia & Pacific; East Asia; Western Europe; Eastern Europe; Middle East & Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Chile, Rest of Latin America, China, Japan, South Korea, India, ASEAN Countries, Australia & New Zealand, Rest of South Asia and Pacific, Germany, Italy, France, United Kingdom, Spain, BENELUX, Nordic Countries, Rest of Western Europe, Russia, Hungary, Poland, Rest of Eastern Europe, Saudi Arabia, Türkiye, South Africa, Other African Union, Rest of Middle East & Africa |
| Key Segments Covered | Product, Lumen, Application, End User, and Region |
| Key Companies Profiled | Vygon (UK) Ltd; Becton, Dickinson and Company; Cardinal Health, Inc.; ICU Medical, Inc.; Kimal Plc; Polymedicure; Teleflex Incorporated; AngioDynamics; B. Braun Medical Ltd; Haolang Technology (Foshan) Limited Co., Ltd.; Medical Components, Inc; Argon Medical; Access Vascular, Inc.; Utah Medical Products, Inc.; Biowy Corporation; Medi-Tech Devices; Footprint Medical Incorporated; PFM Medical, Inc.; HuskMedical; NeoMedical; Cook Medical |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
The global PICC market value totaled USD 1,008.5 million in 2023.
The peripherally inserted central catheter market is set to reach USD 1,037.0 million in 2024.
Global sales are expected to total USD 1,289.9 million by 2034.
The target market grew at a CAGR of 2.1% between 2018 and 2023.
Global demand is projected to grow at 2.2% CAGR through 2034.
The United States market value is set to total USD 545.82 million in 2034.
India market value is anticipated to reach USD 70.16 in 2034.
The power injected PICC segment held a prominent share of 54.5% in 2023.
It is used to deliver medications and other treatments directly to the larger central veins.
A long, thin tube inserted through a vein in arm and passed to larger veins near the heart.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Volume) Analysis 2019 to 2023 and Forecast, 2024 to 2034 7. Global Market Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 9.1. Conventional PICC 9.2. Power Injected PICC 9.3. Neonatal PICC 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Lumen 10.1. Single Lumen 10.2. Double Lumen 10.3. Multiple Lumen 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 11.1. Chemotherapy 11.2. Long-term IV Infusion 11.3. Parenteral Nutrition 11.4. Blood Transfusion 11.5. Difficult Intravenous Access 11.6. Others 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 12.1. Hospitals 12.2. Cancer Research Institutes 12.3. Long Term Care Centers 12.4. Independent Infusion Centers 12.5. Ambulatory Surgical Center 12.6. Home Care Settings 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 13.1. North America 13.2. Latin America 13.3. East Asia 13.4. South Asia & Pacific 13.5. Western Europe 13.6. Eastern Europe 13.7. Middle East & Africa 14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034 19. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 20. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 21. Market Structure Analysis 22. Competition Analysis 22.1. Vygon (UK) Ltd 22.2. Cardinal Health 22.3. Becton, Dickinson and Company 22.4. Cardinal Health, Inc. 22.5. ICU Medical, Inc. 22.6. Kimal Plc 22.7. Polymedicure 22.8. Teleflex Incorporated 22.9. AngioDynamics 22.10. B. Braun Medical Ltd 22.11. Haolang Technology (Foshan) Limited Co., Ltd. 22.12. Medical Components, Inc 22.13. Argon Medical 22.14. Access Vascular, Inc. 22.15. Utah Medical Product, Inc. 22.16. Biowy Corporation 22.17. Medi-Tech Devices 22.18. Footprint Medical Incorporated 22.19. PFM Medical, Inc. 22.20. HuskMedical 22.21. NeoMedical 22.22. Cook Medical 22.23. PFM Medical, Inc. 22.24. HuskMedical 22.25. NeoMedical 22.26. Cook Medical 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Peripherally Inserted Central Catheter (PICC) Market
